FlaggedRx← Medication recall checkHome
Class III · Lower riskRecall completed

Gabapentin

Unlikely to cause harm — often a labeling or packaging issue.

Does this affect you?
Check your lot numberLot # G177092, Exp. 11/24
Where it was soldNationwide in the USA and Puerto Rico
Find the lot number printed on your box or bottle. If it matches — and you take this medicine — call your pharmacist. Don't stop a prescribed medicine on your own.

What happened

Presence of Foreign Tablets/Capsules: Pharmacist reported presence of some Gabapentin tablets 800 mg comingled in Gabapentin 600 mg 500 count bottles.

What to do

  1. Check the lot number and expiry on your medicine against the recall above.
  2. Talk to your pharmacist or doctor before changing anything — don't stop on your own.
  3. Report any problems to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).

Who makes it

Made byScieGen Pharmaceuticals Inc., Hauppauge, NY 11788
Brand nameGABAPENTIN
Generic nameGABAPENTIN
Active ingredient(s)GABAPENTIN
Distributed by / forSciegen Pharmaceuticals Inc
NDC50228-177-05
Show the full FDA record
Full product labelGabapentin Tablets, USP 600 mg, 500 tablets per bottle, RX Only, Manufactured by ScieGen Pharmaceuticals Inc., Hauppauge, NY 11788, NDC: 50228-177-05.
Recalling firmSciegen Pharmaceuticals Inc
DistributionNationwide in the USA and Puerto Rico
Quantity4,392 bottles
Recall initiated2023-02-17
Report date2023-03-08
Recall completed2024-06-17
Recall numberD-0354-2023
ClassificationClass III
FDA statusTerminated
Origin on fileHauppauge NY United States

Related

Gabapentin recallsRecent drug recallsCheck another medication

Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗

This is public FDA recall information, not medical advice. A recall does not always mean your specific bottle is affected. Never stop a prescribed medicine without asking your pharmacist or doctor.